Patents by Inventor Rainer Netzer

Rainer Netzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Examining the Activity of Ion Channels
    Publication number: 20070281330
    Abstract: The present invention relates to a method for examining the activity of ion channels, comprising the following steps: providing a sample comprising ion channels; and determining a value of a measuring parameter as an indicator of the activity of the ion channels; characterized in that said determining of the value of the measuring parameter is performed at a temperature of ? about 10° C.
    Type: Application
    Filed: January 14, 2005
    Publication date: December 6, 2007
    Inventors: Andreas Ebneth, Rainer Netzer, Ulrike Hahn
  • Voltage-gated potassium channel and its use for development of therapeutics
    Patent number: 6984501
    Abstract: The invention relates to a novel tension-dependent potassium channel protein Kv6.2 (SEQ ID NO:1). The Kv6.2 gene is expressed preferably in the myocardium or in the hippocampus. Novel functional heteromultimeric potassium channels having high affinity with propafenone are formed in conjunction with subunit Kv2.1. According to the invention, said novel potassium channels are used in test systems which are suitable of identifying substances modulating, opening or closing the Kv2,1/Kv6.2 channels and which can be used as therapeutic agents.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: January 10, 2006
    Assignee: Evotec Oai AG
    Inventors: Rainer Netzer, Olaf Pongs
  • Modulatory binding site in potassium channels for screening and finding new active ingredients
    Patent number: 6472165
    Abstract: A selective modulatory retigabine binding potassium channel receptor site containing subunits KCNQ2 and KCNQ3, and a method for directly selectively modulating that receptor site by administering retigabine to a cell preparation of the potassium channel.
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: October 29, 2002
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Chris Rundfeldt, Rainer Netzer